OMB No. 1545-1505 Orphan Drug Credit

Form 8820

 Attach to your return. Attachment

Sequence No. 103 Department of the Treasury

Internal Revenue Service

Name(s) shown on return Identifying number

Current Year Credit

1 1

2 2

3

4

3

4

Form 8820 (2001)

Part I

Tax Liability Limit (See Who Must File Form 3800 to find out if you complete Part II or file Form 3800.)

● Individuals. Enter the amount from Form 1040, line 40

5

Corporations. Enter the amount from Form 1120, Schedule J, line 3; Form 1120-A,

Part I, line 1; or the applicable line of your return

●

●

8a 8a

Credit for child and dependent care expenses (Form 2441, line 9) 8b

Credit for the elderly or the disabled (Schedule R (Form 1040), line 20)

b

8d

Foreign tax credit

d

8e

Possessions tax credit (Form 5735, line 17 or 27)

8f f

8g g

Credit for fuel from a nonconventional source

h

Qualified electric vehicle credit (Form 8834, line 20)

Add lines 8a through 8l 8m

9 Net income tax. Subtract line 8m from line 7. If zero, skip lines 10 through 13 and enter -0- on line 14 9

6 Alternative minimum tax:

● Individuals. Enter the amount from Form 6251, line 28

● Corporations. Enter the amount from Form 4626, line 15 6

● Estates and trusts. Enter the amount from Form 1041, Schedule I, line 39

10 Tentative minimum tax (see instructions):

● Individuals. Enter the amount from Form 6251, line 26

10

● Corporations. Enter the amount from Form 4626, line 13

● Estates and trusts. Enter the amount from Form 1041,

Schedule I, line 37

11

Enter 25% (.25) of the excess, if any, of line 11 over $25,000 (see instructions)

13

Subtract line 13 from line 9. If zero or less, enter -0-

13

14

Orphan drug credit allowed for the current year. Enter the smaller of line 4 or line 14 here

and on Form 1040, line 50; Form 1120, Schedule J, line 6d; Form 1120-A, Part I, line 4a; Form

1041, Schedule G, line 2c; or the applicable line of your return 15

Part II



Mortgage interest credit (Form 8396, line 11)

c 8c

5 Regular tax before credits:

7 Add lines 5 and 6 7

12

Enter the greater of line 10 or line 12

11



12

Cat. No. 11208S

Qualified clinical testing expenses paid or incurred during the tax year

Current year credit. Multiply line 1 by 50% (.50) (see instructions)

Pass-through orphan drug credit(s) from an S corporation, partnership, estate, or trust

Total current year orphan drug credit. Add lines 2 and 3

i

Adoption credit (Form 8839, line 14) 8h

General Instructions

Purpose of Form

Who Must File

An individual, estate, trust, organization, or

corporation that elects to claim an orphan

drug credit, or any S corporation,

partnership, estate, or trust that allocates

the credit to its shareholders, partners, or

beneficiaries must complete this form and

attach it to its income tax return.

Use Form 8820 to claim the orphan drug

credit. The credit is 50% of qualified

clinical testing expenses paid or incurred

during the tax year. See section 45C and

Regulations section 1.28-1 for details. Definitions

Qualified clinical testing expenses.

Generally, qualified clinical testing

● In sections 41(b)(2) and (3), “clinical

testing” is substituted for “qualified

research” and

Section references are to the Internal

Revenue Code unless otherwise noted.

District of Columbia first-time homebuyer credit (Form 8859, line 11) 8i

j

For Paperwork Reduction Act Notice, see back of form.

k

l

Child tax credit (Form 1040, line 48)

Education credits (Form 8863, line 18)

8j

8k

Estates and trusts. Enter the sum of the amounts from Form 1041, Schedule G, lines 1a

and 1b, or the amount from the applicable line of your return

Net regular tax. Subtract line 8m from line 5. If zero or less, enter -0-

15

14



expenses are amounts paid or incurred by

the taxpayer that would be described as

qualified research expenses under section

41, with the following modifications:

Qualified clinical testing expenses do not

include expenses to the extent they are

● 100% (instead of 65% or 75%) of

contract research expenses are treated as

clinical testing expenses.

2001

e Rate reduction credit (Form 1040, line 47)

8l

m
Form 8820 (2001) Page 2

Specific Instructions

Figure any orphan drug credit from your

own trade or business on lines 1 and 2.

Skip lines 1 and 2 if you are claiming only

a credit that was allocated to you from an

S corporation, a partnership, an estate, or

trust.

Who Must File Form 3800

If for this year you have more than one of

the credits included in the general

business credit, a carryback or

carryforward of any of these credits, an

orphan drug credit from a passive activity,

or general credits from an electing large

partnership (Schedule K-1 (Form 1065-B)),

you must complete Form 3800, General

Business Credit, instead of completing Part

II of Form 8820, to figure the tax liability

limit.

The general business credit consists of

the following credits.

Line 2

Line 3

Line 4 

S corporations and partnerships.

● Investment (Form 3468).

● Work opportunity (Form 5884).

● Research (Form 6765).

● Low-income housing (Form 8586).

● Enhanced oil recovery (Form 8830).

● Disabled access (Form 8826).

● Renewable electricity production

(Form 8835).

● Indian employment (Form 8845).

● Employer social security and Medicare

taxes paid on certain employee tips

(Form 8846).

● Contributions to selected community

development corporations (Form 8847).

● Alcohol used as fuel (Form 6478).

● Trans-Alaska pipeline liability fund.

● Orphan drug (Form 8820).

funded by a grant, contract, or otherwise

by a governmental entity or another person.

Clinical testing. Generally, clinical testing

means any human clinical testing that

meets all four of the following conditions.

1. The testing is carried out under an

exemption for a drug being tested for a

rare disease or condition under section

505(i) of the Federal Food, Drug, and

Cosmetic Act (Act).

2. The testing occurs after the date the

drug is designated under Act section 526

and before the date on which an

application for the drug is approved under

Act section 505(b) (or, if the drug is a

biological product, before the date the

drug is licensed under section 351 of the

Public Health Service Act).

3. The testing is conducted by or for the

taxpayer to whom the designation under

Act section 526 applies.

4. The testing relates to the use of the

drug for the rare disease or condition for

which it was designated under Act section

526.

Rare disease or condition. A rare disease

or condition is one which afflicts:

● 200,000 or fewer persons in the United

States or

● More than 200,000 persons in the United

States, but for which there is no

reasonable expectation of recovering the

cost of developing and making available a

drug in the United States for the disease

from sales of the drug in the United States.

The above determinations are made as

of the date the drug is designated under

Act section 526.

Testing Not Eligible for the

Credit

The credit is not allowed for clinical testing

conducted outside the United States

unless there is an insufficient U.S. testing

population and the testing is conducted by

a U.S. person or by another person not

related to the taxpayer. Testing conducted

either inside or outside the United States

by a corporation to which section 936

applies is not eligible for the orphan drug

credit.

Coordination With the

Research Credit

Qualified clinical testing expenses used to

figure the orphan drug credit cannot also

be used to figure the credit for increasing

research activities. However, any of these

expenses that are also qualified research

expenses must be included in base period

research expenses when figuring the credit

for increasing research activities in a later

tax year.

Line 1

The empowerment zone employment

credit (Form 8844), while a component of

the general business credit, is figured

separately on Form 8844 and is never

carried to Form 3800.

Line 15

Line 12

The time needed to complete and file

this form will vary depending on individual

circumstances. The estimated average time

is:

Recordkeeping 7 hr., 10 min.

Preparing and sending

the form to the IRS 1 hr., 9 min.

If you have comments concerning the

accuracy of these time estimates or

suggestions for making this form simpler,

we would be happy to hear from you. See

the instructions for the tax return with

which this form is filed.

Paperwork Reduction Act Notice. We

ask for the information on this form to

carry out the Internal Revenue laws of the

United States. You are required to give us

the information. We need it to ensure that

you are complying with these laws and to

allow us to figure and collect the right

amount of tax.

You are not required to provide the

information requested on a form that is

subject to the Paperwork Reduction Act

unless the form displays a valid OMB

control number. Books or records relating

to a form or its instructions must be

retained as long as their contents may

become material in the administration of

any Internal Revenue law. Generally, tax

returns and return information are

confidential, as required by section 6103.

Learning about the

law or the form 1 hr. ● Welfare-to-work (Form 8861).

Line 10

Members of a controlled group of

corporations or group of businesses

under common control. The group is

treated as a single taxpayer and the credit

allowed each member is based on its

proportionate share of the qualified clinical

testing expenses of the group. Enter on

line 1 this member’s share of the group’s

qualified clinical testing expenses.

Reduce the deduction for qualified clinical

testing expenses otherwise allowable on

your income tax return by the amount of

the credit shown on line 2. If the credit

exceeds the amount allowed as a

deduction for the tax year, reduce the

amount chargeable to the capital account

for the year for such expenses by the

amount of the excess. See section 280C(b)

for special rules.

Enter the amount of credit that was

allocated to you as a shareholder, partner,

or beneficiary.

Estates and trusts.

Allocate the orphan drug credit on line 4

among the shareholders or partners.

Attach Form 8820 to Form 1120S or 1065

and on Schedule K-1 show the credit for

each shareholder or partner. Electing large

partnerships include this credit in “general

credits.”

Allocate the orphan drug credit on line 4

between the estate or trust and the

beneficiaries in the same proportion as

income was allocated. On the dotted line

to the left of line 4, the estate or trust

should enter its share of the credit. Label it

“1041 Portion” and use this amount in Part

II (or on Form 3800, if required) to figure

the credit to take on Form 1041. On

Schedule K-1, show each beneficiary’s

share of the portion allocated to

beneficiaries.

Although you may not owe alternative

minimum tax (AMT), you generally must

still compute the tentative minimum tax

(TMT) to figure your credit. For a small

corporation exempt from the AMT under

section 55(e), enter zero. Otherwise,

complete and attach the applicable AMT

form or schedule and enter the TMT on

line 10.

See section 38(c)(3) for special rules that

apply to married couples filing separate

returns, controlled corporate groups,

regulated investment companies, real

estate investment trusts, and estates and

trusts.

If you cannot use part of the credit

because of the tax liability limit (line 14 is

smaller than line 4), carry it back 1 year

and then forward up to 20 years. See the

Instructions for Form 3800 for details.

● New markets (Form 8874).